Ambulatory management of pulmonary embolism: a pragmatic evaluation
See also Baglin T. Fifty per cent of patients with pulmonary embolism can be treated as outpatients. This issue, pp 2404–5; Erkens PMG, Gandara E, Wells P, Shen AY‐H, Bose G, Le Gal G, Rodger M, Prins MH, Carrier M. Safety of outpatient treatment in acute pulmonary embolism. This issue, pp 2412–7. S...
Saved in:
Published in | Journal of thrombosis and haemostasis Vol. 8; no. 11; pp. 2406 - 2411 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.11.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | See also Baglin T. Fifty per cent of patients with pulmonary embolism can be treated as outpatients. This issue, pp 2404–5; Erkens PMG, Gandara E, Wells P, Shen AY‐H, Bose G, Le Gal G, Rodger M, Prins MH, Carrier M. Safety of outpatient treatment in acute pulmonary embolism. This issue, pp 2412–7.
Summary. Background: Patients diagnosed with pulmonary embolism should be considered for treatment on an outpatient basis; however, this practise is not accepted in many centers. Objectives: Review the safety and efficacy of ambulatory management of patients with pulmonary embolism at our institution. Patients/Methods: This was a retrospective single center cohort study of consecutive patients diagnosed with idiopathic or secondary pulmonary embolism between January 2003 and January 2008 at the London Health Sciences Centre in London, Ontario, Canada. Patients were eligible for outpatient management of pulmonary embolism if they were hemodynamically stable, did not require oxygen therapy, did not require parenteral narcotics for pain management, and were not felt to be high risk for a major hemorrhage. Patients were assessed at 3 months for thrombosis recurrence and major bleeding episodes. Results: Six hundred and thirty‐nine patients were included in the study, of which 314 (49.1%; 95% CI 45.2, 53.1) were managed as outpatients; among these there were three (0.95%; 95% CI, 0.25, 3) thrombotic recurrences and three hemorrhagic events. There were nine deaths (2.9%; 95% CI, 1.4, 5.6), all due to underlying cancer and all occurring after the first 7 days of treatment. Conclusions: Outpatient management of uncomplicated pulmonary embolism seems safe and effective in the absence of other indications for hospital admission. |
---|---|
AbstractList | Patients diagnosed with pulmonary embolism should be considered for treatment on an outpatient basis; however, this practise is not accepted in many centers.
Review the safety and efficacy of ambulatory management of patients with pulmonary embolism at our institution.
This was a retrospective single center cohort study of consecutive patients diagnosed with idiopathic or secondary pulmonary embolism between January 2003 and January 2008 at the London Health Sciences Centre in London, Ontario, Canada. Patients were eligible for outpatient management of pulmonary embolism if they were hemodynamically stable, did not require oxygen therapy, did not require parenteral narcotics for pain management, and were not felt to be high risk for a major hemorrhage. Patients were assessed at 3 months for thrombosis recurrence and major bleeding episodes.
Six hundred and thirty-nine patients were included in the study, of which 314 (49.1%; 95% CI 45.2, 53.1) were managed as outpatients; among these there were three (0.95%; 95% CI, 0.25, 3) thrombotic recurrences and three hemorrhagic events. There were nine deaths (2.9%; 95% CI, 1.4, 5.6), all due to underlying cancer and all occurring after the first 7 days of treatment.
Outpatient management of uncomplicated pulmonary embolism seems safe and effective in the absence of other indications for hospital admission. BACKGROUNDPatients diagnosed with pulmonary embolism should be considered for treatment on an outpatient basis; however, this practise is not accepted in many centers. OBJECTIVESReview the safety and efficacy of ambulatory management of patients with pulmonary embolism at our institution. PATIENTS/METHODSThis was a retrospective single center cohort study of consecutive patients diagnosed with idiopathic or secondary pulmonary embolism between January 2003 and January 2008 at the London Health Sciences Centre in London, Ontario, Canada. Patients were eligible for outpatient management of pulmonary embolism if they were hemodynamically stable, did not require oxygen therapy, did not require parenteral narcotics for pain management, and were not felt to be high risk for a major hemorrhage. Patients were assessed at 3 months for thrombosis recurrence and major bleeding episodes. RESULTSSix hundred and thirty-nine patients were included in the study, of which 314 (49.1%; 95% CI 45.2, 53.1) were managed as outpatients; among these there were three (0.95%; 95% CI, 0.25, 3) thrombotic recurrences and three hemorrhagic events. There were nine deaths (2.9%; 95% CI, 1.4, 5.6), all due to underlying cancer and all occurring after the first 7 days of treatment. CONCLUSIONSOutpatient management of uncomplicated pulmonary embolism seems safe and effective in the absence of other indications for hospital admission. See also Baglin T. Fifty per cent of patients with pulmonary embolism can be treated as outpatients. This issue, pp 2404-5; Erkens PMG, Gandara E, Wells P, Shen AY-H, Bose G, Le Gal G, Rodger M, Prins MH, Carrier M. Safety of outpatient treatment in acute pulmonary embolism. This issue, pp 2412-7.Summary. Background: Patients diagnosed with pulmonary embolism should be considered for treatment on an outpatient basis; however, this practise is not accepted in many centers. Objectives: Review the safety and efficacy of ambulatory management of patients with pulmonary embolism at our institution. Patients-Methods: This was a retrospective single center cohort study of consecutive patients diagnosed with idiopathic or secondary pulmonary embolism between January 2003 and January 2008 at the London Health Sciences Centre in London, Ontario, Canada. Patients were eligible for outpatient management of pulmonary embolism if they were hemodynamically stable, did not require oxygen therapy, did not require parenteral narcotics for pain management, and were not felt to be high risk for a major hemorrhage. Patients were assessed at 3 months for thrombosis recurrence and major bleeding episodes. Results: Six hundred and thirty-nine patients were included in the study, of which 314 (49.1%; 95% CI 45.2, 53.1) were managed as outpatients; among these there were three (0.95%; 95% CI, 0.25, 3) thrombotic recurrences and three hemorrhagic events. There were nine deaths (2.9%; 95% CI, 1.4, 5.6), all due to underlying cancer and all occurring after the first 7 days of treatment. Conclusions: Outpatient management of uncomplicated pulmonary embolism seems safe and effective in the absence of other indications for hospital admission. See also Baglin T. Fifty per cent of patients with pulmonary embolism can be treated as outpatients. This issue, pp 2404–5; Erkens PMG, Gandara E, Wells P, Shen AY‐H, Bose G, Le Gal G, Rodger M, Prins MH, Carrier M. Safety of outpatient treatment in acute pulmonary embolism. This issue, pp 2412–7. Summary. Background: Patients diagnosed with pulmonary embolism should be considered for treatment on an outpatient basis; however, this practise is not accepted in many centers. Objectives: Review the safety and efficacy of ambulatory management of patients with pulmonary embolism at our institution. Patients/Methods: This was a retrospective single center cohort study of consecutive patients diagnosed with idiopathic or secondary pulmonary embolism between January 2003 and January 2008 at the London Health Sciences Centre in London, Ontario, Canada. Patients were eligible for outpatient management of pulmonary embolism if they were hemodynamically stable, did not require oxygen therapy, did not require parenteral narcotics for pain management, and were not felt to be high risk for a major hemorrhage. Patients were assessed at 3 months for thrombosis recurrence and major bleeding episodes. Results: Six hundred and thirty‐nine patients were included in the study, of which 314 (49.1%; 95% CI 45.2, 53.1) were managed as outpatients; among these there were three (0.95%; 95% CI, 0.25, 3) thrombotic recurrences and three hemorrhagic events. There were nine deaths (2.9%; 95% CI, 1.4, 5.6), all due to underlying cancer and all occurring after the first 7 days of treatment. Conclusions: Outpatient management of uncomplicated pulmonary embolism seems safe and effective in the absence of other indications for hospital admission. |
Author | KOVACS, M. J. HAWEL, J. D. REKMAN, J. F. LAZO‐LANGNER, A. |
Author_xml | – sequence: 1 givenname: M. J. surname: KOVACS fullname: KOVACS, M. J. – sequence: 2 givenname: J. D. surname: HAWEL fullname: HAWEL, J. D. – sequence: 3 givenname: J. F. surname: REKMAN fullname: REKMAN, J. F. – sequence: 4 givenname: A. surname: LAZO‐LANGNER fullname: LAZO‐LANGNER, A. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20626624$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkMtOwzAQRS1URB_wCyg7Vg1-xXWQWFQVUFAlNmVt2YldpYrjECfQ_j0OfWzBG1-N750ZnzEYVK7SAEQIxiic-22MEsKnM05YjGGoQpJyFO8uwOj8MDjplJAhGHu_hRClCYZXYIghw4xhOgKLuVVdKVvX7CMrK7nRVldt5ExUd6V1lQx1bZUrC28fIhnVjdxY2RZZpL9k2QXlqmtwaWTp9c3xnoCP56f1Yjldvb-8LuaraUZnCZryjEqucsyU5CgxGNIcG0xIjnPDDJd5xqTKs1zzRHEYIhmhkhoWljaSJopMwN2hb924z077VtjCZ7osZaVd50WaUAZnnNM_nZyyFGIEYXDygzNrnPeNNqJuCht-LRAUPWuxFT1G0SMVPWvxy1rsQvT2OKRTVufn4AluMDweDN9Fqff_bize1stekR8S_I99 |
CitedBy_id | crossref_primary_10_1016_j_thromres_2016_05_010 crossref_primary_10_1016_j_annemergmed_2017_10_022 crossref_primary_10_1586_erc_11_179 crossref_primary_10_1016_j_thromres_2024_01_014 crossref_primary_10_1016_j_mcna_2011_08_003 crossref_primary_10_1093_eurheartj_ehab373 crossref_primary_10_1016_j_thromres_2011_08_025 crossref_primary_10_1016_S1280_4703_13_65165_8 crossref_primary_10_1111_j_1538_7836_2010_04055_x crossref_primary_10_1160_TH14_12_1036 crossref_primary_10_1378_chest_11_2301 crossref_primary_10_1007_s11239_014_1097_y crossref_primary_10_1016_j_amjmed_2019_05_040 crossref_primary_10_1016_j_thromres_2015_10_035 crossref_primary_10_1111_j_1538_7836_2011_04388_x crossref_primary_10_1111_jth_12040 crossref_primary_10_1016_S0246_0289_12_59051_1 crossref_primary_10_1002_14651858_CD010019_pub4 crossref_primary_10_1016_j_amjmed_2016_03_035 crossref_primary_10_1016_j_chest_2018_01_035 crossref_primary_10_1185_03007995_2015_1062748 crossref_primary_10_1007_s11606_021_07289_0 crossref_primary_10_1002_14651858_CD010019_pub3 crossref_primary_10_1186_s12245_017_0144_9 crossref_primary_10_1002_14651858_CD010019_pub2 crossref_primary_10_1016_j_thromres_2013_08_012 crossref_primary_10_1016_j_thorsurg_2015_07_007 crossref_primary_10_2217_cpr_12_63 crossref_primary_10_1016_j_annemergmed_2012_05_041 crossref_primary_10_1016_j_thromres_2017_06_024 crossref_primary_10_1183_16000617_00006614 crossref_primary_10_1186_s12931_015_0203_9 crossref_primary_10_1007_s11845_012_0878_6 crossref_primary_10_1016_j_thromres_2014_07_031 crossref_primary_10_1177_1076029616674827 crossref_primary_10_1016_j_thromres_2018_05_008 crossref_primary_10_1513_AnnalsATS_201411_548OC crossref_primary_10_1182_bloodadvances_2019001223 crossref_primary_10_1136_bmjopen_2015_009251 crossref_primary_10_6064_2012_502378 crossref_primary_10_1016_S1283_0771_13_65019_7 crossref_primary_10_7326_M18_1206 crossref_primary_10_1177_08971900211000704 crossref_primary_10_1002_ajh_22066 crossref_primary_10_1007_s11239_011_0562_0 crossref_primary_10_1093_ije_dyz117 crossref_primary_10_1111_jth_12146 crossref_primary_10_1016_S0140_6736_11_60824_6 crossref_primary_10_1111_jth_12944 crossref_primary_10_1007_s40138_017_0144_3 crossref_primary_10_1016_j_hrtlng_2022_09_010 crossref_primary_10_1177_1076029618811082 crossref_primary_10_1016_j_jmv_2015_05_002 crossref_primary_10_1016_j_jen_2020_02_018 crossref_primary_10_1111_acem_12809 crossref_primary_10_1136_thoraxjnl_2018_211539 crossref_primary_10_1016_j_jemermed_2016_11_020 crossref_primary_10_1160_TH11_04_0263 crossref_primary_10_1016_j_revmed_2024_04_003 crossref_primary_10_1016_j_amjmed_2012_07_025 crossref_primary_10_1097_MBC_0b013e32835a72c2 crossref_primary_10_1177_1076029618808922 crossref_primary_10_1016_j_acvd_2023_11_012 crossref_primary_10_1016_j_thromres_2017_05_001 |
Cites_doi | 10.1182/blood.V106.11.910.910 10.1093/eurheartj/ehi588 10.1056/NEJM199709043371002 10.1378/chest.08-2258 10.7861/clinmedicine.8-4-388 10.1111/j.1538-7836.2010.03958.x 10.1160/TH08-05-0285 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E 10.1056/NEJM199709043371001 10.1161/01.CIR.102.2.211 10.1056/NEJM199603143341101 10.1055/s-0037-1613787 10.1056/NEJMoa025313 10.1161/01.CIR.0000137826.09715.9C 10.1111/j.1538-7836.2009.03345.x 10.1001/archinte.165.7.733 10.7326/0003-4819-140-3-200402030-00008 10.7326/0003-4819-152-9-201005040-00008 10.1164/rccm.200906-0970OC 10.1056/NEJM199603143341102 10.1160/TH08-05-0319 10.1111/j.1365-2796.2007.01785.x 10.1055/s-0037-1616520 10.2214/ajr.148.2.263 10.1378/chest.09-0608 10.1378/chest.06-2921 10.1007/BF01062714 10.1111/j.1538-7836.2005.01204.x |
ContentType | Journal Article |
Copyright | 2010 International Society on Thrombosis and Haemostasis 2010 International Society on Thrombosis and Haemostasis. |
Copyright_xml | – notice: 2010 International Society on Thrombosis and Haemostasis – notice: 2010 International Society on Thrombosis and Haemostasis. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7U1 7U2 C1K |
DOI | 10.1111/j.1538-7836.2010.03981.x |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Risk Abstracts Safety Science and Risk Environmental Sciences and Pollution Management |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic Risk Abstracts Safety Science and Risk Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE MEDLINE - Academic Risk Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-7836 |
EndPage | 2411 |
ExternalDocumentID | 10_1111_j_1538_7836_2010_03981_x 20626624 JTH3981 |
Genre | article Journal Article |
GeographicLocations | Canada, Ontario |
GeographicLocations_xml | – name: Canada, Ontario |
GroupedDBID | --- 05W 0SF 1OC 24P 29L 2WC 31~ 33P 36B 3SF 4.4 52U 52V 53G 5GY 5VS 66C 8-0 8-1 A00 AAESR AAEVG AAHHS AALRI AAONW AASGY AAXRX AAXUO AAZKR ABCUV ABDBF ABJNI ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADVLN ADXAS ADZMN AEEZP AEIMD AENEX AEQDE AFBPY AFEBI AFGKR AFPWT AFZJQ AHMBA AIACR AITUG AIURR AIWBW AJAOE AJBDE AKRWK ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMRAJ AMYDB ATUGU AZBYB AZVAB BAWUL BHBCM BMXJE BOGZA BRXPI C45 CAG COF CS3 DCZOG DIK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EBS EJD EMB EMK ESX F5P FDB FIJ FUBAC G-S GODZA HZ~ IHE IPNFZ IX1 KBYEO LATKE LEEKS LH4 LITHE LOXES LUTES LW6 LYRES M41 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ O66 O9- OIG OK1 OVD P2P P2W P4E PQQKQ ROL SUPJJ SV3 TEORI TR2 W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WVDHM WYJ ZZTAW AFJKZ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7U1 7U2 C1K |
ID | FETCH-LOGICAL-c4751-8c4a8bd26ba815f204d2f233d2df6f8adc6abdcde85b80475c34a4f6195fa45b3 |
IEDL.DBID | DR2 |
ISSN | 1538-7933 1538-7836 |
IngestDate | Fri Oct 25 00:34:41 EDT 2024 Fri Oct 25 01:57:17 EDT 2024 Thu Sep 26 17:44:48 EDT 2024 Sat Sep 28 07:51:05 EDT 2024 Sat Aug 24 00:49:49 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | 2010 International Society on Thrombosis and Haemostasis. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4751-8c4a8bd26ba815f204d2f233d2df6f8adc6abdcde85b80475c34a4f6195fa45b3 |
Notes | Presented in part at the 50th Annual Meeting of the American Society of Hematology, San Fransisco, CA, USA, 8 December 2009. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | http://www.jthjournal.org/article/S1538783622066715/pdf |
PMID | 20626624 |
PQID | 846902100 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_954607884 proquest_miscellaneous_846902100 crossref_primary_10_1111_j_1538_7836_2010_03981_x pubmed_primary_20626624 wiley_primary_10_1111_j_1538_7836_2010_03981_x_JTH3981 |
PublicationCentury | 2000 |
PublicationDate | November 2010 |
PublicationDateYYYYMMDD | 2010-11-01 |
PublicationDate_xml | – month: 11 year: 2010 text: November 2010 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England |
PublicationTitle | Journal of thrombosis and haemostasis |
PublicationTitleAlternate | J Thromb Haemost |
PublicationYear | 2010 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 1997; 337 2007; 261 1987; 148 2004; 140 2009 2008; 8 2010; 181 1995; 2 2008; 100 2009; 136 2001; 86 2004; 110 1998; 17 2003; 349 2005; 165 2000; 102 2007; 132 2006; 27 2005; 106 2000; 83 2010; 152 2009; 7 2005; 3 1996; 334 2010; 8 21251192 - J Thromb Haemost. 2010 Nov;8(11):2404-5 Kovacs (10.1111/j.1538-7836.2010.03981.x_bb0020) 2000; 83 (10.1111/j.1538-7836.2010.03981.x_bb0035) 1997; 337 Jimenez (10.1111/j.1538-7836.2010.03981.x_bb0110) 2007; 132 Kovacs (10.1111/j.1538-7836.2010.03981.x_bb0075) 2010; 8 Schulman (10.1111/j.1538-7836.2010.03981.x_bb0085) 2005; 3 10.1111/j.1538-7836.2010.03981.x_bb0095 Lee (10.1111/j.1538-7836.2010.03981.x_bb0100) 2003; 349 Koopman (10.1111/j.1538-7836.2010.03981.x_bb0025) 1996; 334 Newcombe (10.1111/j.1538-7836.2010.03981.x_bb0090) 1998; 17 Sanchez (10.1111/j.1538-7836.2010.03981.x_bb0120) 2010; 181 Janjua (10.1111/j.1538-7836.2010.03981.x_bb0060) 2008; 100 Jimenez (10.1111/j.1538-7836.2010.03981.x_bb0130) 2009; 136 Dorfman (10.1111/j.1538-7836.2010.03981.x_bb0065) 1987; 148 Levine (10.1111/j.1538-7836.2010.03981.x_bb0030) 1996; 334 Wan (10.1111/j.1538-7836.2010.03981.x_bb0045) 2004; 110 Giannitsis (10.1111/j.1538-7836.2010.03981.x_bb0135) 2000; 102 Couturaud (10.1111/j.1538-7836.2010.03981.x_bb0070) 2001; 86 Aylin (10.1111/j.1538-7836.2010.03981.x_bb0145) 2008; 8 Jerjes‐Sanchez (10.1111/j.1538-7836.2010.03981.x_bb0050) 1995; 2 Simonneau (10.1111/j.1538-7836.2010.03981.x_bb0010) 1997; 337 Bova (10.1111/j.1538-7836.2010.03981.x_bb0125) 2009; 7 Park (10.1111/j.1538-7836.2010.03981.x_bb0150) 2009; 136 Heit (10.1111/j.1538-7836.2010.03981.x_bb0040) 2005; 106 Wells (10.1111/j.1538-7836.2010.03981.x_bb0055) 2005; 165 Quinlan (10.1111/j.1538-7836.2010.03981.x_bb0015) 2004; 140 Carrier (10.1111/j.1538-7836.2010.03981.x_bb0080) 2010; 152 Aujesky (10.1111/j.1538-7836.2010.03981.x_bb0115) 2006; 27 Aujesky (10.1111/j.1538-7836.2010.03981.x_bb0140) 2007; 261 Donze (10.1111/j.1538-7836.2010.03981.x_bb0105) 2008; 100 |
References_xml | – volume: 27 start-page: 476 year: 2006 end-page: 81 article-title: Validation of a model to predict adverse outcomes in patients with pulmonary embolism publication-title: Eur Heart J – year: 2009 – volume: 132 start-page: 24 year: 2007 end-page: 30 article-title: Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy publication-title: Chest – volume: 334 start-page: 682 year: 1996 end-page: 7 article-title: Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low‐molecular‐weight heparin administered at home. The Tasman Study Group publication-title: N Engl J Med – volume: 100 start-page: 756 year: 2008 end-page: 61 article-title: Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review publication-title: Thromb Haemost – volume: 86 start-page: 980 year: 2001 end-page: 4 article-title: Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta‐analysis publication-title: Thromb Haemost – volume: 334 start-page: 667 year: 1996 end-page: 81 article-title: A comparison of low‐molecular‐weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep‐vein thrombosis publication-title: N Engl J Med – volume: 337 start-page: 657 year: 1997 end-page: 62 article-title: Low‐molecular‐weight heparin in the treatment of patients with venous thromboembolism publication-title: N Engl J Med – volume: 261 start-page: 597 year: 2007 end-page: 604 article-title: Validation of a clinical prognostic model to identify low‐risk patients with pulmonary embolism publication-title: J Intern Med – volume: 337 start-page: 663 year: 1997 end-page: 9 article-title: A comparison of low‐molecular‐weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: evaluations dans l’Embolie Pulmonaire publication-title: N Engl J Med – volume: 181 start-page: 168 year: 2010 end-page: 73 article-title: Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study publication-title: Am J Respir Crit Care Med – volume: 8 start-page: 1926 year: 2010 end-page: 32 article-title: Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism publication-title: J Thromb Haemost – volume: 3 start-page: 692 year: 2005 end-page: 4 article-title: Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients publication-title: J Thromb Haemost – volume: 100 start-page: 943 year: 2008 end-page: 8 article-title: Prospective validation of the pulmonary embolism severity index. A clinical prognostic model for pulmonary embolism publication-title: Thromb Haemost – volume: 7 start-page: 938 year: 2009 end-page: 44 article-title: Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow‐up publication-title: J Thromb Haemost – volume: 2 start-page: 227 year: 1995 end-page: 9 article-title: Streptokinase and Heparin versus Heparin alone in massive pulmonary embolism: a randomized controlled trial publication-title: J Thromb Thrombolysis – volume: 136 start-page: 983 year: 2009 end-page: 90 article-title: Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample publication-title: Chest – volume: 148 start-page: 263 year: 1987 end-page: 6 article-title: Occult pulmonary embolism: a common occurrence in deep venous thrombosis publication-title: AJR Am J Roentgenol – volume: 140 start-page: 175 year: 2004 end-page: 83 article-title: Low‐molecular‐weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta‐analysis of randomized, controlled trials publication-title: Ann Intern Med – volume: 152 start-page: 578 year: 2010 end-page: 89 article-title: Systematic review: case‐fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism publication-title: Ann Intern Med – volume: 136 start-page: 974 year: 2009 end-page: 82 article-title: Troponin‐based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis publication-title: Chest – volume: 349 start-page: 146 year: 2003 end-page: 53 article-title: Low‐molecular‐weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer publication-title: N Engl J Med – volume: 83 start-page: 209 year: 2000 end-page: 11 article-title: Outpatient treatment of pulmonary embolism with dalteparin publication-title: Thromb Haemost – volume: 165 start-page: 733 year: 2005 end-page: 8 article-title: A randomized trial comparing 2 low‐molecular‐weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism publication-title: Arch Intern Med – volume: 17 start-page: 857 year: 1998 end-page: 72 article-title: Two‐sided confidence intervals for the single proportion: comparison of seven methods publication-title: Stat Med – volume: 8 start-page: 388 year: 2008 end-page: 92 article-title: Trends in hospital admissions for pulmonary embolism in England: 1996/1997 to 2005/2006 publication-title: Clin Med – volume: 106 year: 2005 article-title: Estimated annual number of incident and recurrent, non‐fatal and fatal venous thromboembolism (VTE) events in the US publication-title: Blood – volume: 110 start-page: 744 year: 2004 end-page: 9 article-title: Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta‐analysis of the randomized controlled trials publication-title: Circulation – volume: 102 start-page: 211 year: 2000 end-page: 7 article-title: Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism publication-title: Circulation – volume: 106 year: 2005 ident: 10.1111/j.1538-7836.2010.03981.x_bb0040 article-title: Estimated annual number of incident and recurrent, non‐fatal and fatal venous thromboembolism (VTE) events in the US publication-title: Blood doi: 10.1182/blood.V106.11.910.910 contributor: fullname: Heit – volume: 27 start-page: 476 year: 2006 ident: 10.1111/j.1538-7836.2010.03981.x_bb0115 article-title: Validation of a model to predict adverse outcomes in patients with pulmonary embolism publication-title: Eur Heart J doi: 10.1093/eurheartj/ehi588 contributor: fullname: Aujesky – volume: 337 start-page: 663 year: 1997 ident: 10.1111/j.1538-7836.2010.03981.x_bb0010 article-title: A comparison of low‐molecular‐weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: evaluations dans l’Embolie Pulmonaire publication-title: N Engl J Med doi: 10.1056/NEJM199709043371002 contributor: fullname: Simonneau – volume: 136 start-page: 983 year: 2009 ident: 10.1111/j.1538-7836.2010.03981.x_bb0150 article-title: Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample publication-title: Chest doi: 10.1378/chest.08-2258 contributor: fullname: Park – volume: 8 start-page: 388 year: 2008 ident: 10.1111/j.1538-7836.2010.03981.x_bb0145 article-title: Trends in hospital admissions for pulmonary embolism in England: 1996/1997 to 2005/2006 publication-title: Clin Med doi: 10.7861/clinmedicine.8-4-388 contributor: fullname: Aylin – volume: 8 start-page: 1926 year: 2010 ident: 10.1111/j.1538-7836.2010.03981.x_bb0075 article-title: Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2010.03958.x contributor: fullname: Kovacs – volume: 100 start-page: 943 year: 2008 ident: 10.1111/j.1538-7836.2010.03981.x_bb0105 article-title: Prospective validation of the pulmonary embolism severity index. A clinical prognostic model for pulmonary embolism publication-title: Thromb Haemost doi: 10.1160/TH08-05-0285 contributor: fullname: Donze – volume: 17 start-page: 857 year: 1998 ident: 10.1111/j.1538-7836.2010.03981.x_bb0090 article-title: Two‐sided confidence intervals for the single proportion: comparison of seven methods publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E contributor: fullname: Newcombe – volume: 337 start-page: 657 year: 1997 ident: 10.1111/j.1538-7836.2010.03981.x_bb0035 article-title: Low‐molecular‐weight heparin in the treatment of patients with venous thromboembolism publication-title: N Engl J Med doi: 10.1056/NEJM199709043371001 – volume: 102 start-page: 211 year: 2000 ident: 10.1111/j.1538-7836.2010.03981.x_bb0135 article-title: Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism publication-title: Circulation doi: 10.1161/01.CIR.102.2.211 contributor: fullname: Giannitsis – volume: 334 start-page: 667 year: 1996 ident: 10.1111/j.1538-7836.2010.03981.x_bb0030 article-title: A comparison of low‐molecular‐weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep‐vein thrombosis publication-title: N Engl J Med doi: 10.1056/NEJM199603143341101 contributor: fullname: Levine – volume: 83 start-page: 209 year: 2000 ident: 10.1111/j.1538-7836.2010.03981.x_bb0020 article-title: Outpatient treatment of pulmonary embolism with dalteparin publication-title: Thromb Haemost doi: 10.1055/s-0037-1613787 contributor: fullname: Kovacs – volume: 349 start-page: 146 year: 2003 ident: 10.1111/j.1538-7836.2010.03981.x_bb0100 article-title: Low‐molecular‐weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa025313 contributor: fullname: Lee – volume: 110 start-page: 744 year: 2004 ident: 10.1111/j.1538-7836.2010.03981.x_bb0045 article-title: Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta‐analysis of the randomized controlled trials publication-title: Circulation doi: 10.1161/01.CIR.0000137826.09715.9C contributor: fullname: Wan – volume: 7 start-page: 938 year: 2009 ident: 10.1111/j.1538-7836.2010.03981.x_bb0125 article-title: Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow‐up publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2009.03345.x contributor: fullname: Bova – volume: 165 start-page: 733 year: 2005 ident: 10.1111/j.1538-7836.2010.03981.x_bb0055 article-title: A randomized trial comparing 2 low‐molecular‐weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism publication-title: Arch Intern Med doi: 10.1001/archinte.165.7.733 contributor: fullname: Wells – volume: 140 start-page: 175 year: 2004 ident: 10.1111/j.1538-7836.2010.03981.x_bb0015 article-title: Low‐molecular‐weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta‐analysis of randomized, controlled trials publication-title: Ann Intern Med doi: 10.7326/0003-4819-140-3-200402030-00008 contributor: fullname: Quinlan – volume: 152 start-page: 578 year: 2010 ident: 10.1111/j.1538-7836.2010.03981.x_bb0080 article-title: Systematic review: case‐fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism publication-title: Ann Intern Med doi: 10.7326/0003-4819-152-9-201005040-00008 contributor: fullname: Carrier – ident: 10.1111/j.1538-7836.2010.03981.x_bb0095 – volume: 181 start-page: 168 year: 2010 ident: 10.1111/j.1538-7836.2010.03981.x_bb0120 article-title: Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200906-0970OC contributor: fullname: Sanchez – volume: 334 start-page: 682 year: 1996 ident: 10.1111/j.1538-7836.2010.03981.x_bb0025 article-title: Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low‐molecular‐weight heparin administered at home. The Tasman Study Group publication-title: N Engl J Med doi: 10.1056/NEJM199603143341102 contributor: fullname: Koopman – volume: 100 start-page: 756 year: 2008 ident: 10.1111/j.1538-7836.2010.03981.x_bb0060 article-title: Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review publication-title: Thromb Haemost doi: 10.1160/TH08-05-0319 contributor: fullname: Janjua – volume: 261 start-page: 597 year: 2007 ident: 10.1111/j.1538-7836.2010.03981.x_bb0140 article-title: Validation of a clinical prognostic model to identify low‐risk patients with pulmonary embolism publication-title: J Intern Med doi: 10.1111/j.1365-2796.2007.01785.x contributor: fullname: Aujesky – volume: 86 start-page: 980 year: 2001 ident: 10.1111/j.1538-7836.2010.03981.x_bb0070 article-title: Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta‐analysis publication-title: Thromb Haemost doi: 10.1055/s-0037-1616520 contributor: fullname: Couturaud – volume: 148 start-page: 263 year: 1987 ident: 10.1111/j.1538-7836.2010.03981.x_bb0065 article-title: Occult pulmonary embolism: a common occurrence in deep venous thrombosis publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.148.2.263 contributor: fullname: Dorfman – volume: 136 start-page: 974 year: 2009 ident: 10.1111/j.1538-7836.2010.03981.x_bb0130 article-title: Troponin‐based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis publication-title: Chest doi: 10.1378/chest.09-0608 contributor: fullname: Jimenez – volume: 132 start-page: 24 year: 2007 ident: 10.1111/j.1538-7836.2010.03981.x_bb0110 article-title: Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy publication-title: Chest doi: 10.1378/chest.06-2921 contributor: fullname: Jimenez – volume: 2 start-page: 227 year: 1995 ident: 10.1111/j.1538-7836.2010.03981.x_bb0050 article-title: Streptokinase and Heparin versus Heparin alone in massive pulmonary embolism: a randomized controlled trial publication-title: J Thromb Thrombolysis doi: 10.1007/BF01062714 contributor: fullname: Jerjes‐Sanchez – volume: 3 start-page: 692 year: 2005 ident: 10.1111/j.1538-7836.2010.03981.x_bb0085 article-title: Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2005.01204.x contributor: fullname: Schulman |
SSID | ssj0019520 |
Score | 2.32911 |
Snippet | See also Baglin T. Fifty per cent of patients with pulmonary embolism can be treated as outpatients. This issue, pp 2404–5; Erkens PMG, Gandara E, Wells P,... Patients diagnosed with pulmonary embolism should be considered for treatment on an outpatient basis; however, this practise is not accepted in many centers.... BACKGROUNDPatients diagnosed with pulmonary embolism should be considered for treatment on an outpatient basis; however, this practise is not accepted in many... See also Baglin T. Fifty per cent of patients with pulmonary embolism can be treated as outpatients. This issue, pp 2404-5; Erkens PMG, Gandara E, Wells P,... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2406 |
SubjectTerms | Aged Ambulatory Care - methods Cancer Cardiology - methods Cohort Studies Female Heparin, Low-Molecular-Weight - therapeutic use Hospitals Humans low‐molecular‐weight heparin Male Middle Aged Mortality outcomes outpatient Outpatients Oxygen Oxygen - therapeutic use pain pulmonary embolism Pulmonary Embolism - therapy Recurrence Retrospective Studies Reviews therapy thromboembolism Thromboembolism - therapy Treatment Outcome venous thromboembolism |
Title | Ambulatory management of pulmonary embolism: a pragmatic evaluation |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1538-7836.2010.03981.x https://www.ncbi.nlm.nih.gov/pubmed/20626624 https://search.proquest.com/docview/846902100 https://search.proquest.com/docview/954607884 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JSwMxFA7iQby4L3UjB69TZrI1461USynUg7TQW0gyiUiXKV1A_fUmmWm1LiDibWAmk8l7eZPvJV--AHBtZZoomqYRxjUaEYlspBhSkZIOb8hM8zicGdm5Z60eafdpv-Q_-b0whT7EasLNR0b4X_sAl2q2HuQ-WP0uhJKhhVOeVD2eTHDNs7tuH1ZKUklKg0JjUcQl8euknm9ftD5SfYGf62g2DEfNXTBYNqRgoQyqi7mq6tdPGo__09I9sFOiVlgvutk-2DDjA7DVKdflD0GjPlL-HLB8-gJHK0INzC2cLIauo7u6oRmpfPg0G91ACSdT-Ri0YuG72vgR6DXvuo1WVB7PEGlSo0nENZFcZYgpyRNqUUwyZBHGGcoss9w5mkmV6cxwqnjsimhMJLEuY6NWEqrwMdgc52NzCmCNIo01NTjI_cRG2RhpqUzCWWZRKisgWbpCTAoVDvEhe3HWEd46wltHBOuI5wqAS58JFzJ-HUSOTb6YCe6nBFyqG__8SEoJc-CJkwo4Kdy9qhfFLgdkyN1hwWm__iDR7rb81dlfC56D7cBdCDshL8DmfLowlw4SzdVV6Oxvrb786A |
link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3JTsMwELUQSMCFfSmrD1xTJd7qcEMFVKDlgIrEzbIdGyHapiqtBHw9tpMWyiIhxC1S4jie8cRvxuM3ABxZmSaKpmmEcY1GRCIbKYZUpKTDGzLTPA41I1vXrHFLLu_oXVkOyJ-FKfghJgE3bxnhf-0N3Aekp63cW6s_hlCmaOGUJ1UHKOec9WNfx-H0ZsIllaQ0cDQWbZwbP53W8-2bpteqLwB0Gs-GBel8GXTGQynyUB6ro6Gq6tdPLI__NNYVsFQCV3hSzLRVMGN6a2C-VW7Nr4P6SVf5UmD54AV2Jzk1MLewP-q4ue46h6ar8s7DU_cYStgfyPtAFwvfCcc3wO35WbveiMoKDZEmNZpEXBPJVYaYkjyhFsUkQxZhnKHMMsudrplUmc4Mp4rHronGRBLrnDZqJaEKb4LZXt4z2wDWKNJYU4MD409slI2RlsoknGUWpbICkrEuRL8g4hAfHBgnHeGlI7x0RJCOeK4AOFaacFbjt0Jkz-SjJ8F9VMB5u_HPj6SUMIefOKmArULfk35R7NxAhtwdFrT26w8Sl-2Gv9r5a8NDsNBot5qieXF9tQsWQypDOBi5B2aHg5HZdwhpqA7CzH8Dha4BDw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JSwMxFA6iIF7cl7rm4HXKTLZmvIla6oqIgreQVUTbKbUF9debZKbVuoCIt4GZTCZvmXwvefkeALtO5pmieZ5g3KAJkcgliiGVKOnxhjSap7Fm5PkFa92Qk1t6W-U_hbMwJT_EaMEteEb8XwcH7xo37uTBWcMphCpDC-c8q3s8OUWYB8IBIF2NqKSynEaKxrKNj-LHs3q-fdP4VPUFf47D2TgfNefAw3AkZRrKQ33QV3X9-onk8X-GOg9mK9gK90s7WwATtrMIps-rjfklcLDfVqEQWNF7ge1RRg0sHOwOHr2l-76hbavi8f6pvQcl7PbkXSSLhe9048vgpnl0fdBKqvoMiSYNmiVcE8mVQUxJnlGHUmKQQxgbZBxz3GuaSWW0sZwqnvomGhNJnA_ZqJOEKrwCJjtFx64B2KBIY00tjnw_qVUuRVoqm3FmHMplDWRDVYhuScMhPoQvXjoiSEcE6YgoHfFcA3CoM-F9JmyEyI4tBk-ChzUBH-umPz-SU8I8euKkBlZLdY_6RakPAhnyd1hU2q8_SJxct8LV-l8b7oDpy8OmODu-ON0AMzGPIZ6K3AST_d7Abnl41Ffb0e7fAHKg_68 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ambulatory+management+of+pulmonary+embolism%3A+a+pragmatic+evaluation&rft.jtitle=Journal+of+thrombosis+and+haemostasis&rft.au=Kovacs%2C+M+J&rft.au=Hawel%2C+J+D&rft.au=Rekman%2C+J+F&rft.au=Lazo-Langner%2C+A&rft.date=2010-11-01&rft.eissn=1538-7836&rft.volume=8&rft.issue=11&rft.spage=2406&rft_id=info:doi/10.1111%2Fj.1538-7836.2010.03981.x&rft_id=info%3Apmid%2F20626624&rft.externalDocID=20626624 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-7933&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-7933&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-7933&client=summon |